oAlert.pl
WARNING: RECALLED PRODUCT
PL EN

Mitocin 20 mg

In batch no. 0-20022AB an out-of-specification result was found due to the presence of visible particles in the product intended for solution for injection. Potential effects: embolism, inflammation, inflammatory reactions, local or systemic complications.

Download the app and stay informed

Get instant notifications about recalled products and protect your family.

Mitocin 20 mg
Risk Level
Critical
Manufacturer
podmiot odpowiedzialny: Vygoris Limited podmiot, który uzyskał zgodę na czasowe dopuszczenie do obrotu produktu leczniczego: Profarm Sp. z o.o. ul. Słoneczna 96, 05-500 Stara Iwiczna
Batch Number
0-20022AB
Recall Date
17.09.2021
View official statement

Important Information

What You Should Know

Recommendations

Do not use the product from batch 0-20022AB. Entities holding this batch should immediately stop its use and return it to the wholesaler. Patients who received the product from this batch and experien...

Actions Taken

The Chief Pharmaceutical Inspector withdrew batch 0-20022AB of Mitocin 20 mg from the market throughout the country and granted the decision immediate enforceability.

Need Help?

If you feel unwell after consuming this product, contact your doctor or call the poison control center.

FAQ

Frequently Asked Questions

Is this product safe to consume?
No. This product has been recalled due to: In batch no. 0-20022AB an out-of-specification result was found due to the presence of visible particles in the product intended for solution for injection. Potential effects: embolism, inflammation, inflammatory reactions, local or systemic complications.
What should I do if I already bought this?
Stop using the product immediately. Return it to the store for a full refund. If you consumed it and feel unwell, contact your doctor.
Which batches are affected?
Affected batch numbers: 0-20022AB

Related

Other Recalled Products